Fatal hepatitis and renal failure during treatment with nimesulide

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 153-155

  Schattner, Ami ^a,b   Sokolovskaya, N ^a   Cohen, J ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acute renal failure: drug induced; Adverse drug reaction; Hepatitis: drug induced; Hepatitis: fulminant nimesulide; Non steroidal antiinflammatory drugs

Indexed keywords

DICLOFENAC; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KNEE OSTEOARTHRITIS; LIVER TOXICITY; NEPHROTOXICITY; PRIORITY JOURNAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTEREMIA; FATAL OUTCOME; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEPATIC ENCEPHALOPATHY; HEPATITIS, TOXIC; HUMANS; KIDNEY FAILURE, ACUTE; LIVER FAILURE; NECROSIS; SULFONAMIDES;

EID: 0033969529     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00612.x     Document Type: Article

References (9)

1. 1 Gay GR. Another side effect of NSAIDs. J Am Med Assoc 1990; 264: 2677-78.
2. 2 Hawkey CJ. COX-2 inhibitors. Lancet 1999; 353: 307-14.
3. 3 Boelsterli UA, Zimmerman HJ, Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol 1995; 25: 207-35.
4. 4 Van-Steenbergen W, Peeters P, De-Bondt J et al. Nimesulide-induced acute hepatitis: evidence from six cases. J Hepat 1998; 29: 135-41.
5. 5 Epstein M. Hepatorenal syndrome. In: Epstein M. ed. The Kidney in Liver Disease, 3rd edn. Baltimore: Williams & Wilkins, 1988:89-118.
6. 6 Orme MUE. Nonsteroidal antiinflammatory drugs and the kidney. Br Med J 1986; 292: 1621-22.
7. 7 Moore K, Wenden J, Frazer M, Karani J, Williams R, Badr K. Plasma endolhelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992; 327: 1774-78.
8. 8 James AF, Hendry BM. Endothelin antagonists in renal disease. Lancet 1997; 350: 381-82.
9. 9 McCormick PA, Kennedy F, Curry M, Traynor O. COX-2 inhibitor and fulminant hepatic failure. (Letter.) Lancet 1999; 353: 40-41.